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Abstract
Background: Terpenoids constitute a large family of natural products, attracting commercial interest for a variety
of uses as flavours, fragrances, drugs and alternative fuels. Saccharomyces cerevisiae offers a versatile cell factory, as
the precursors of terpenoid biosynthesis are naturally synthesized by the sterol biosynthetic pathway.
Results: S. cerevisiae wild type yeast cells, selected for their capacity to produce high sterol levels were targeted for
improvement aiming to increase production. Recyclable integration cassettes were developed which enable the
unlimited sequential integration of desirable genetic elements (promoters, genes, termination sequence) at any
desired locus in the yeast genome. The approach was applied on the yeast sterol biosynthetic pathway genes
HMG2, ERG20 and IDI1 resulting in several-fold increase in plant monoterpene and sesquiterpene production. The
improved strains were robust and could sustain high terpenoid production levels for an extended period.
Simultaneous plasmid-driven co-expression of IDI1 and the HMG2 (K6R) variant, in the improved strain background,
maximized monoterpene production levels. Expression of two terpene synthase enzymes from the sage species
Salvia fruticosa and S. pomifera (SfCinS1, SpP330) in the modified yeast cells identified a range of terpenoids which
are also present in the plant essential oils. Co-expression of the putative interacting protein HSP90 with cineole
synthase 1 (SfCinS1) also improved production levels, pointing to an additional means to improve production.
Conclusions: Using the developed molecular tools, new yeast strains were generated with increased capacity to
produce plant terpenoids. The approach taken and the durability of the strains allow successive rounds of
improvement to maximize yields.
Background
An important class of secondary metabolites, terpenoids
and isoprenoids contribute more than 50,000 compounds
to the rich chemical diversity of natural product structures
[1]. Many of them have attracted commercial interest for
their medicinal properties or as flavour and fragrance
additives in the food and cosmetic industry. Among them
taxol, a diterpene from yew, has successfully been estab-
lished in the clinic as a major antineoplastic agent, artemi-
sinin is an effective antimalarial agent and sclareol is
industrially important diterpene used by the fragrance
industry [2-4]. Recently, attention has also focused on
microbial produced terpenes as biodiesel [5,6] All terpe-
noids are biosynthesized from two C5 precursors, isopen-
tenyl diphosphate (IPP) and dimethylallyl diphosphate
(DMAPP) [7]. Two distinct and independent biosynthetic
routes to IPP formation exist. In yeast and mammals IPP
originates from acetyl-CoA through the intermediate
mevalonic acid (MVA) (Figure 1). In eubacteria and plastid
associated isoprenoids in algae and plants, IPP is derived
by the condensation of pyruvate and glyceraldehyde-3-
phosphate, via the 1-deoxyxylulose-5-phosphate (DXP)
pathway. IPP then gives rise through the action of prenyl-
transferase enzymes to the higher order building blocks,
geranyl pyrophosphate (GPP; C10), farnesyl pyrophosphate
(FPP; C15) and geranylgeranyl pyrophosphate (GGPP; C20)
[7-9]. Monoterpenes (C10) are known to play important
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plants and their environments, often playing a protec-
tive role against herbivores and pathogens [10]. Many
plant species, including Salvia sp. (sage), produce and
store large amounts of terpenoid-rich resins and essen-
tial oils in differentiated tissues such as glandular tri-
chomes found on the surface of plant aerial parts
[11,12]. Biosynthesis of monoterpenes and sesquiter-
penes has previously been examined in the secretory
cells of peppermint (Mentha × piperita), an essential
oil-producing plant that belongs to the large Lamia-
ceae family (which also includes sage and basil). Mono-
terpene biosynthesis and accumulation was indeed
shown to localize in the glandular trichomes [12,13].
Saccharomyces cerevisiae is a unicellular eukaryotic
organism traditionally regarded as a model system for
investigating cellular physiology and widely used as a
cell factory for biotechnological applications. Strain
improvement has relied in the past on random muta-
genesis and classical genetic approaches. In recent
years, developments in molecular genetics have made
it possible to introduce specific genetic perturbations
by modifying the promoter strength of a given gene, to
perform gene deletions, or to introduce whole new
genes or biosynthetic pathways. Metabolic engineering
of an amenable organism such as S. cerevisiae aiming
to direct cellular resources and the biosynthetic
machinery towards the production of highly desirable
natural products, can be an environmentally friendly
and economically viable approach to the production of
high-added value compounds [14]. S. cerevisiae offers a
unique advantage for the production of terpenoids, as
the precursors of terpene biosynthesis (GPP, FPP and
GGPP) are naturally synthesized by the sterol biosyn-
thetic pathway. Recent efforts in yeast metabolic engi-
neering for the production of terpenes have pointed to
a significant potential for improvement in the yields of
compounds produced [15-19].
In the current work we aimed to improve yeast
strains in a targeted way while avoiding to introduce
bacterial plasmid sequences into the yeast genome.
The approach was based on recyclable cassette vectors
that enable unlimited modifications of the genome.
Through the use of the cre-lox recombination system
the selection markers can be excised and reused. We
employed this approach to introduce strong inducible
promoter upstream of endogenous yeast genes and to
incorporate at any desired genetic locus extra copies of
genes controlled by strong promoters. When applied
to the terpenoid biosynthetic pathway, this approach
afforded yeast stains which exhibit several fold increase
in the yield of monoterpene and sesquiterpene
production.
Results
Selection of an optimal yeast strain for terpenoid
production
Yeast laboratory and industrial strains are known to
possess a high degree of phenotypic variability towards
adverse growth conditions such as thermal stress, oxida-
tive stress and nutrient limitation. To initiate our yeast
improvement effort for the production of terpenoids,
we selected to test a strain (EG60, Table 1) for which
there was evidence of increased sterol production
(F. Mantzouridou, unpublished data). The plasmid
pJG4-6/SfCinS1, which expresses inducibly the S. fruti-
cosa (Greek sage) cineole synthase 1 fused to a hema-
glutinin tag (HA), was introduced into EG60 cells and
the standard reference laboratory strain BY4741 (Table 1).
Expression of the SfCinS1 was achieved by switching cells
in galactose-based media, and the presence of the protein
was confirmed in western blots using antibodies against
HA (Figure 2C). For the subsequent experimental work, a
non-tagged version of SfCinS1 was used to avoid any
interference of the tag to enzyme activity, as monoterpene
synthases are sensitive to alterations in the N-terminus
(data not shown). Equal amounts of yeast cells were
induced in galactose, and were subsequently transferred in
buffer solution. Sampling of the cells in buffer tended to
yield lower background volatiles. At 24 hours after enzyme
induction the ambient atmosphere of the culture flasks
was sampled by inserting a Solid Phase Microextraction
Figure 1 The Mevalonate pathway of GPP and FPP
biosynthesis in yeast. The non-boxed rectangles show the points
of integration of the introduce plant enzymes producing
monoterpenes and sesquiterpenes. The encircled enzymatic steps
represent targets of modification. Solid lines represent introduction
of extra gene copies (HMG2, IDI1), broken lines show the
introduction of a strong inducible promoter in one of two alleles,
and in dotted line is the deletion of one allele to generate a
haploinsufficient strain.
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Strain Genotype Plasmid description Source
BY4741-01 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0. pJG4-6/SfCinS1 2μ TRP1 PGal1-HA-SfCinS1 This study
BY4741-02 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
BY4741-04 Mat a, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0. pYESmyc/P330 2μ URA3 PGal1-myc-P330 This study
EGY48 Mat a, ura3, trp1, his3, 6xLexA operators::LEU2. Derivative of
the U457.
Erica
Golemis
EGY48-01 Mat a, ura3, trp1, his3, 6xLexA operators::LEU2. Derivative of
the U457.
pYES/SfCinS1-LexA 2μ URA3 PGal1-SfCinS1-LexA This study
EGY48-02 Mat a, ura3, trp1, his3, 6xLexA operators::LEU2. Derivative of
the U457.
pYES-LexA 2μ URA3 PGal1-LexA This study
EG60 Mat a, ura3, trp1, his3, leu2. Erica
Golemis
EG60-01 Mat a, ura3, trp1, his3, leu2 pJG4-6/SfCinS1 2μ TRP1 PGal1-HA-SfCinS1 This study
EG60-02 Mat a, ura3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
EG60-03 Mat a, ura3, trp1, his3, leu2 pYESmyc/P330 2μ URA3 PGal1-myc-P330 This study
EG60-04 Mat a, ura3, trp1, his3, leu2 pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
EG60-05 Mat a, ura3, trp1, his3 leu2 pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYES 2μ URA3 PGal1 This study
EG60-06 Mat a, ura3, trp1, his3 leu2 pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYES/HSP90 2μ URA3
PGal1-HSP90
This study
EG60-07 Mat a, ura3, trp1, his3 leu2 pJG4-4 2μ TRP1 PGal1 - empty vector
EG61 Mat a, ura3, trp1, his3 leu2 This study
KSY10 Mat a, PGal1-HMG2 (K6R)::URA3, trp1, his3, leu2 This study
AM62 Mat a, Δerg6:: HIS5, ura3, trp1, his3, leu2 Derivative of EG60. This study
AM63 Mat a,P Gal1-HMG2 (K6R)::URA3, trp1, his3, leu2. This study
AM63-01 Mat a,P Gal1-HMG2 (K6R)::URA3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM63-02 Mat a,P Gal1-HMG2 (K6R)::URA3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYX143/GDS 2μ LEU2
PTPI1-GDS
This study
AM64 Mat a, URA3-hisG-PGal1-HMG2 (K6R)::HO, trp1, his3, leu2, Δerg6::
HIS5. Derivative of AM63.
This study
AM65 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2. Derivative of
AM64.
This study
AM65-01 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, This study
AM65-02 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3,leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
AM66 Mat a/a, PGal1-HMG2 (K6R) X2::HO, ura3, trp1, his3, leu2.
Derivative of AM63 and KSY10 back-crossed 4 times.
This study
AM66-01 Mat a/a, PGal1-HMG2 (K6R) x2::HO, ura3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM66-02 Mat a/a, PGal1-HMG2 (K6R) x2::HO, ura3, trp1, his3, leu2 pYESmyc/P330 2μ URA3 PGal1-myc-P330 This study
AM66-03 Mat a/a, PGal1-HMG2 -(K6R) x2::HO, ura3, trp1, his3, leu2. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
AM67 Mat a/a, PGal1-HMG2 (K6R) x2, PGal1-HA-ERG20-URA3, trp1,
his3, leu2. Derivative of AM66.
This study
AM67-01 Mat a/a, PGal1-HMG2 (K6R)x2, PGal1-HA-g-URA3, trp1, his3, leu2. pB227/GAL-cre, CEN LEU2 This study
AM67-02 Mat a/a, PGal1 -HMG2 (K6R) x2, PGal1-HA-ERG20-URA3, trp1,
his3, leu2
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM68 Mat a/a, PGal1-HMG2 -(K6R) x2, PGal1-HA-ERG20, ura3, trp1,
his3. Derivative of AM67.
This study
AM68-01 Mat a/a, PGal1-HMG2 (K6R) x2, PGal1-HA-ERG20, ura3, trp1, his3,
leu2
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM68-02 Mat a/a, PGal1-HMG2 -(K6R) x2, PGal1-HA-ERG20, ura3, trp1,
his3, leu2
pYESmyc/P330 2μ URA3 PGal1-myc-P330 This study
AM68-03 Mat a/a, PGal1-HMG2 (K6R) x2, PGal1-HA-ERG20, ura3, trp1, his3,
leu2
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
AM68-04 Mat a/a, PGal1-HMG2 (K6R) x2, PGal1-HA-ERG20, ura3, trp1, his3,
leu2
pYESmyc/P330 2μ URA3 PGal1-myc-P330, pYIC1/IDI1 2μ LEU2
PGal1-IDI1
This study
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analyzed by Gas Chromatography-Mass Spectrometry
(GC-MS). As anticipated, cells harboring the SfSinS1 con-
struct produced cineole (Figure 2A), whereas cells with
empty vector yielded no significant terpenoids (Figure 2B).
EG60-01 cells expressing SfCinS1 produced 2.5-fold
higher levels of cineole compared to BY4741-01 cells
(Table 1), confirming the initial hypothesis that strains
with increased sterol levels would produce higher terpene
yields (Figure 2D).
Integration of a K6R variant of HMG2 into the genome
To improve terpene production by the EG60 strain, we
sought to incorporate alterations in the sterol biosyn-
thetic pathway stably into the chromosomal genome
avoiding the integration of exogenous bacterial plasmid
Table 1 Yeast strains used in this study (Continued)
AM69 Mat a/a, PGal1-HMG2 -(K6R)x2, PGal1-ERG20-URA3, trp1, his3,
leu2, Δerg9:: HIS5. Derivative of AM67.
This study
AM70 Mat a/a, PGal1-HMG2 -(K6R) x2, PGal1-HA-ERG20, ura3, trp1,
his3, leu2, Δerg9:: HIS5. Derivative of AM68.
This study
AM70-01 Mat a/a, PGal1-HMG2 (K6R) x2, PGal1-HA-ERG20, ura3, trp1, his3,
leu2, Δerg9:: HIS5.
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM70-02 Mat a/a, PGal1-HMG2 -(K6R) x2, PGal1-HA-ERG20, ura3, trp1,
his3, leu2, Δerg9:: HIS5.
pYESmyc/P330 2μ URA3 PGAL1-myc-P330 This study
AM70-03 Mat a/a, PGal1-HMG2 (K6R) x2,PGal1-HA-ERG20, ura3, trp1, his3,
leu2, Δerg9:: HIS5.
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
AM70-04 Mat a/a, PGal1-HMG2 (K6R) x2,PGal1-HA-ERG20, ura3, trp1, his3,
leu2, Δerg9:: HIS5.
pYESmyc/P330 2μ URA3 PGAL1-myc-P330, pYIC1/IDI1 2μ LEU2
PGal1-IDI1
This study
AM74 Mat a/a, PGal1-HMG2 (K6R)x2::HO, PGal1-HA-ERG20,P Adh1-myc::
tHMG1, URA3, trp1, his3, leu2. Derivative of AM68.
This study
AM75 Mat a/a, PGal1-HMG2 (K6R) x2::HO, PGal1-HA-ERG20,P Adh1-myc::
tHMG1, URA3, trp1, his3, leu2, Δerg9::HIS5. Derivative of AM70.
This study
AM76 Mat a/a, PGal1-HMG2 (K6R) x2::HO, ura3, trp1, his3, leu2, Δerg9::
HIS5. Derivative of AM66.
This study
AM76-01 Mat a/a, PGal1-HMG2 (K6R) x2::HO, ura3, trp1, his3, leu2, Δerg9::
HIS5.
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
AM77 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1-HIS5.
Derivative of AM65.
This study
AM77-01 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1-HIS5. pB227/GAL-cre, CEN LEU2 This study
AM77-02 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGAL1-IDI1-
HIS5.
pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM78 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1.
Derivative of AM77.
This study
AM78-01 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1 This study
AM78-02 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1P Gal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1
This study
AM78-03 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1, pYIC1 2μ LEU2 PGal1
This study
AM78-03 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc 2μ URA3 PGal1-
myc, pYIC1/IDI1 2μ LEU2 PGal1-HA-IDI1
This study
AM78-04 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYIC1/IDI1 2μ LEU2
PGal1-HA-IDI1
This study
AM78-05 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1, pYIC1/IDI1 2μ LEU2 PGal1-HA-IDI1
This study
AM78-06 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc 2μ URA3 PGal1-
myc-, pYIC1/HMG2(K6R) 2μ LEU2P Gal1-HA-HMG2 (K6R)
This study
AM78-07 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYESmyc/IDI1 2μ URA3
PGal1-myc-IDI1, pYIC1/HMG2(K6R) 2μ LEU2P Gal1-HA-HMG2
(K6R)
This study
AM78-08 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYES 2μ URA3 PGal1 This study
AM78-09 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYES/HSP90 2μ URA3
PGal1-HSP90
This study
AM78-10 Mat a,P Gal1-HMG2 (K6R), ura3, trp1, his3, leu2:: PGal1-IDI1. pJG4-4/SfCinS1 2μ TRP1 PGal1-SfCinS1, pYIC1/HMG2(K6R) 2μ
LEU2 PGal1-HA-HMG2 (K6R)
This study
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viously developed vector (M4366), containing the HO-
hisG-URA3-hisG-poly-HO cassette, was employed [20].
The vector is designed to enable integration by homolo-
gous recombination at the HO locus, which in the vast
majority of laboratory yeast strains is already mutated
[20,21]. A cassette composed of the galactose promoter,
a multicloning site and the terminator sequence was
inserted into the vector’s multicloning site. The first
gene chosen in the pathway was HMG2, which encodes
an enzyme responsible for converting 3-hydroxy-3-
methylglutaryl (HMG)-CoA into mevalonic acid
(Figure 1) [22]. HMGR is a key enzyme in sterol bio-
synthesis and is subject to feedback regulation in yeasts,
plants and animals [23]. Yeast has 2 isozymes of HMGR
t e r m e dh m g 1 pa n dh m g 2 pa n de n c o d e db yHMG1 and
HMG2 genes respectively. Mutation of lysine 6 into
arginine in HMG2 is known to stabilize the protein
from protein degradation [24]. The variant K6R HMG2
was inserted at the multicloning site of the M4366-PGal1
resulting in the HOR-PGal1-HMG2 (K6R)-ts-hisG-URA3-
h i s G - H O LD N Af r a g m e n t( C O D 1 ;F i g u r e3 A ) .C O D 1
was then used to transform EG60 cells, creating strain
AM63. Colonies which were capable of growing in
media lacking uracil were selected and tested by PCR
for proper integration. The hisG-URA3-hisG cassette
was excised by inducing recombination in the AM63
strain between the hisG repeats flanking the URA3
gene, leaving behind the PGal1-HMG2 (K6R)-ts, thus
generating strain AM65 (Table 1). The pJG4-4/SfCinS1
plasmid was introduced into the AM63 strain and cells
were tested for cineole production (AM63-01; Table1).
A reproducible 2.8-fold increase in cineole production
compared to the parental strain EG60-02 (Table 1) was
observed (Figure 3B). Conversion of the strain into a
diploid homozygous strain for the PGal1-HMG2 (K6R)
AM66 (Table 1) led to an additional production boost
(Figure 3B). To assess whether additional improvements
in cineole production could be attained, the Picea abies
geranyl diphosphate synthase (GDS) gene was co-
expressed. GDS catalyzes the condensation of DMAPP
and IPP to GPP, which is the substrate for monoterpene
synthases [25]. Co-expression of GDS with SfCinS1 in
strain AM63-02 (Table 1) led to almost doubling of
cineole production compared to the AM63-01 strain.
This was further improved when AM63-02 cells were
supplemented with exogenous GPP added in the buffer
medium (Figure 3C). These results indicated additional
potential for higher production levels in the AM63
strain.
Upregulation of ERG20 and haploinsufficiency for ERG9
To further modify the biosynthetic pathway, the ERG20
g e n ew a sc h o s e na st a r g e tf o ru p r e g u l a t i o n .ERG20
A
B
C
D
BY4741-02                           EG60-02 
Figure 2 Production of cineole in yeast.( A )E G 6 0 - 0 1y e a s tc e l l s
expressing SfCinS1, under the control of the galactose inducible
promoter, were sampled by SPME and analyzed by gas
chromatography. (B) EG60-06 cells harboring empty vector do not
produce cineole. (C) Western blot showing expression of SfCinS1,
lane 1 protein extracts from EG60 cells, lane 2 protein extracts from
EG60-01 cells harboring the SfCinS1 grown in glucose, and in lane 3
grown in galactose, which induces protein expression.
(D) Quantification of cineole production, in BY4741-02 cells
(reference strain) versus EG60-02 cells.
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responsible for FPP biosynthesis, but also produces GPP
(Figure 2) [26]. Since ERG20 is an essential gene in
yeast, the diploid strain AM66 was chosen for modifica-
tion of one of the two alleles. To achieve this, we devel-
oped a set recombination cassettes which enable the
integration of a strong inducible or constitutive
promoter, and the subsequent excision of the selection
marker. This strategy enables the consecutive integra-
tion of promoter elements at any desired locus.
The new cassettes were named COD2 and COD3
(Figure 4A, B). The COD2 cassette was used in a PCR
reaction with primers containing ERG20 promoter
flanking sequence The galactose promoter was then
integrated in the promoter region of one of the ERG20
alleles in AM66 cells generating the AM67 strain
(Table 1). Verification of the integration site was per-
formed by PCR using primers from the galactose pro-
moter and ERG20. Colonies that contained the
promoter integration were transformed with the pB227/
Gal-cre plasmid expressing the enzyme Cre recombinase
under the control of the galactose promoter (Strain
AM67-01; Table 1) [27]. Induction of Cre expression led
to the excision of the URA3 cassette from the genome,
l e a v i n gb e h i n do n l yt h eg a l a c t o s ep r o m o t e r .T h ef i n a l
s t r a i nA M 6 8 - 0 1( T a b l e1 )w a sf o u n dt oh a v ea na d d i -
tional 30% increase in cineole produced (Figure 4C).
An additional means to enhance the availability of iso-
prene units as substrates for the exogenous plant ter-
pene synthases, is to avoid draining towards sterol
synthesis. To this end, ERG9 which encodes squalene
synthase was targeted. ERG9 i st h ee n z y m et h a ta c t s
downstream of ERG20, receiving FPP for its immediate
conversion into squalene (Figure 1). Its deletion in hap-
loid cells leads to viability loss [28], but deletion of one
allele in diploid cells, has no effect. The haploinsufficient
strain for ERG9 is expected to express reduced mRNA
levels for the gene. To generate such strain a loxP-his5-
loxP cassette was employed to delete one of the two
alleles in the AM68 strain and generate the strain
AM70 (Table 1) [27]. When AM70-01 (Table 1) cells
were tested for cineole production, a drastic decrease in
cineole production was observed compared to its paren-
tal AM68-01 strain (Figure 4B).
Since ERG20 produces FPP which is the substrate of
sesquiterpene synthases we tested the strains by overex-
pressing a recently isolated by our group sesquiterpene
synthase homologue (P330) from Salvia pomifera,i n t o
the EG60, AM66, and AM68 and AM70 cells generating
EG60-03, AM66-02, AM68-02 and AM70-02 respec-
tively (Table 1). Induction of enzyme expression and
analysis of the volatiles identified 4 sesquiterpene peaks
(Figure 4E). The highest peak identified, corresponded
to δ-cadinene, and three almost equivalent peaks corre-
sponded to trans-b-caryophyllene, a-copaene and
a-cubebene (identified by GC-MS analysis). Quantita-
tion of sesquiterpenes was carried out on the registered
peak areas of the detected trans-b-caryophyllene, as
compared to a standard trans-b-caryophyllene sample
(Figure 4F). Sesquiterpene production was increased
in all modified yeast strains. Expression of P330
A
B
EG60-01               AM63-01              AM66-01   
 HMG2(K6R)      2X HMG2(K6R) 
C
                                       +GPP 
                   AM63-02   AM63-02 
Figure 3 Integration of HMG2(K6R) variant leads to cineole
production increase. (A) Map of the homologous recombination
cassette designed to integrate a stabilized copy of HMG2(K6R) into
the HO locus under the control of the galactose promoter. The
hisG-URA3-hisG part of the cassette is subsequently excised from
the genome by plating in FOA plates; (B) Cineole production in
AM63 and AM65 cells; (C) Cineole yields in AM63 cells co-expressing
the P. abies geranyl pyrophosphate synthase (GDS). Exogenous GPP
was also added to assess the level of saturation of the system.
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Figure 4 Improved yeast strains generated by strong promoter integration and single allele deletion for ERG9.( A )M a po ft h eC O D 2
cassette, designed for integration of the galactose inducible promoter into promoter regions of endogenous genes. Subsequent to integration,
the loxP-URA3-loxP part of the cassette is removed by excision from the enzyme Cre recombinase; (B) Map of the COD3 cassette, designed for
the integration of the constitutive ADH1 promoter; C) Cineole production increase in AM68-01 cells, which overexpress ERG20, under the
galactose promoter. AM70-01 cells, which are additionally haploinsufficient for ERG9, present substantially reduced levels of cineole production;
(D) Expression of a sesquiterpene synthase P330 from S. pomifera in AM68-02 cells; peak 1, a-cubebene; peak 2, a-copaene; peak 3, trans-b-
caryophyllene; peak 4, δ-cadinene; (E) Trans-b-caryophyllene standard used for quantification (peak 1);. (F) Copaene standard used for
quantification (peak 1); (G) Sesquiterpene yields in the newly developed yeast strains. AM70-02 cells exhibit a substantial yield increase compared
to wild type EG60-03 cells.
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for monoterpenes, resulted in a significant increase
of sesquiterpenes produced, yielding almost 4-fold
increased levels for δ-cadinene and trans-b-caryophyl-
lene (Figure 4D).
Integration of a promoter-IDI1-ts cassette
Τhe gene IDI1 (Figure 1) encodes for an isomerase that
catalyzes an essential step in the sterol pathway, the iso-
merization of IPP to DMAPP. The produced DMAPP is
then taken up by ERG20 to generate GPP. Upon tilting the
balance in favor of DMAPP, an increase in GPP and
monoterpene production is anticipated. To test this, the
open reading frame of IDI1 was cloned into the high copy
number yeast expression plasmid pYES2-myc under the
control of the galactose promoter. IDI1 was co-expressed
together with SfCinS1 in EG60, AM65, AM68, AM70 and
AM76 cells generating the strains EG60-04, AM65-02,
AM68-03, AM70-03 and AM76-01 respectively (Table 1).
A dramatic increase in cineole production caused by IDI1
overexpression, was observed in all strains (Figure 5A).
The highest relative increase occurred in the unmodified
EG60 cells which reached 5-fold higher levels. The highest
absolute levels were produced in the haploid AM65 strain
reaching 400 mg/L. Cineole levels at AM68, AM70, and
AM76 cells were equivalently high (300 mg/L). To
improve the endogenous capacity of our yeast strain to
produce GPP, the approach taken was to introduce an
extra copy of the IDI1 gene into the yeast genome. A new
cassette named COD4 (Figure 5B) was developed which
included the Pgal1-MCS-ts- loxP-his5-loxP. This cassette
can be used to integrate any exogenous gene of interest
under the control of the galactose promoter at any desir-
able locus, and subsequently excise the selection marker
and reuse the integration strategy to incorporate the PGal1-
GeneX-ts at other loci in the yeast genome [27]. The IDI1
orf was cloned into the cassette generating the COD40
construct (Figure 5C).
The 3.1 kb cassette was PCR-amplified using primers
that would add 50 bp flanking sequences from the LEU2
gene, which is mutated in the parental AM65 strain. Cells
which had integrated the CO D 4 0c a s s e t t ew e r ea b l et o
grow in media lacking histidine. The yeast strain was
named AM77 (Table 1). The loxP-his5-loxP part of the
cassette was subsequently excised using Cre recombinase
leaving in the genome only the PGal1-IDI1-ts sequence
(AM78; Table 1). The generated strains were tested for
cineole production by expressing SfCinS1 from the pJG4-4
plasmid (Figure 5C). The IDI1 integration in strain AM78-
01 (Table 1) led to a significant increase in cineole yield
with production reaching 200 mg/L (AM78-01). These
levels are 24-fold higher than the standard reference strain
BY4741-02 (Figure 1), although not surprisingly less than
the levels attained when IDI1 was expressed from a high
A
                      EG60-04   AM65-02    AM68-03   AM70-03   AM76-01 
B
C
D
                      AM65-01       AM78-01        AM78-02 
Figure 5 High levels of IDI1 lead to high monoterpene
production. (A) Co-expression from a plasmid of the yeast IDI1
gene in EG60-04, AM65-02, AM68-03, AM70-03, AM76-01 cells (dark
bars) leads to substantial increase in cineole yields in all strains
tested vs. their corresponding non expressing strains (light grey
bars); (B) Map of COD4 cassette which can accept cDNAs under the
control of the galactose promoter; (C) Map of COD40 cassette
which integrates an extra copy of the IDI1 gene into the
chromosome, under the control of the galactose promoter.
Subsequent to integration, the loxP-his5-loxP part of the cassette is
removed by excision from the Cre recombinase; (D) Cineole
production in AM78-01 and AM78-02 cells, which have a copy of
the PGal1-IDI1-ts in the leu2 locus.
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attained 400 mg/L (Figure 5A, Table 1). When the plasmid
expressing IDI1 was introduced to AM78 cells which car-
ried the extra IDI1 copy in the genome, the cineole yield
reached 485 mg/L surpassing AM65 cells expressing IDI1
(Figure 5A and 5D). These results indicate that by inte-
grating additional copies or resorting to a stronger promo-
ter we can further improve yields at this step. In addition,
we tested sesquiterpene production in AM68 and AM70
cells by co-expressing IDI1 with P330. Again, unlike
monoterpenes, no increase was seen in sesquiterpene pro-
duction upon IDI1 co-expression (data not shown.)
Robustness of improved yeast strains
To assess whether the introduced changes caused
growth impediments in the generated strains, fresh over-
night cultures of EG60, AM66, AM68, AM70 and AM78
cells were resuspended at low density (OD600)i nY P D
or galactose-raffinose based medium. The cultures were
allowed to grow shaking at 30°C and the OD600 was
measured at regular intervals. No inhibitory effect was
observed in any of the tested strains in both media. No
changes in cell viability were observed 5 days after
induction. (Figure 6A). The results suggest that addi-
tional improvements can be undertaken on these strains
to maximize yields further.
Additionally, the release of cineole, over an extended
time period, was examined. The parental EG60-02 cells
together with AM65-01 and AM78-01, harboring the
SfCinS1 construct, were grown at mid-logarithmic phase
and then switched to galactose-raffinose media for
12 hours to induce expression of the genes. Subsequent
to induction the cells were washed and resuspended in
buffer solution. The ambient environment of the flasks
was sampled daily by SPME. As shown in figure 6B,
AM78-01 (-▲-) and AM65-01 (-■-) cells compared to
wild type EG60-02 release significantly higher levels
over an extended period reaching 12 days post-induc-
tion. While the total levels of cineole were lower than in
galactose- raffinose media, the release of cineole for all
strains was maintained over a longer period.
Maximizing production in the improved strains by
plasmid-driven expression
To further explore the potential of the system, the
improved AM78-01 strain expressing SfCinS1, was trans-
formed with combinations of plasmids harboring addi-
tional copies of IDI1 and HMG2 (K6R) or control
vectors. This led to the development of the: AM78-03
strain carrying PGal1-IDI1 in pYESmyc and the control
PGal1 pYIC1 vector; AM78-04 strain carrying the pYES-
myc empty plasmid and the PGal1-IDI1 in pYIC1; AM78-
05 carrying PGal1-IDI1 in pYESmyc and PGal1-IDI1 in
A                        
Ǻ 
C 
AM78      -01       -03       -04       -05       -06       -07 
Figure 6 The new strains are robust and allow further
improvements through plasmid-driven gene expression. (A) The
robustness of the newly developed AM66, AM68, AM70, AM78
strains were tested in a growth assay in galactose based media. No
difference with wild type EG60 cells is observed; (B) AM78-01 cells
(triangle), AM65-01 cells (square), and parental EG60-02 (rhomboid)
cells induced for protein expression were sampled by SPME daily
over a 19 day period and monitored for cineole production; (C)
Co-expression in AM78-05 cells of IDI1 from two high copy number
plasmids did not cause higher cineole production, whereas the
co-expression of IDI1 with HMG2 (K6R) in AM78-07 doubled the
yield.
Ignea et al. Microbial Cell Factories 2011, 10:4
http://www.microbialcellfactories.com/content/10/1/4
Page 9 of 18pYIC1; AM78-06 carrying PGal1-IDI1 in pYESmyc and
PGal1-HMG2 (K6R) in pYIC1 (Table 1, Figure 6C).
Production of cineole in strain AM78-05 appeared to
reach a plateau compared to AM78-03 strain pointing
to saturation at the current balance of the other biosyn-
thetic components. Co-expression of IDI1 with the
HMG2 (K6R) variant in AM78-06 cells doubled cineole
production (Figure 6C). The combination of the two
genes expressed from the chromosomal integrations and
the high copy plasmids in AM78-07 led to a 55-fold
cineole increase from the wild type EG60-02 parental
cells (Figure 2D).
Liquid-Liquid extractions in the improved strains
The SPME sampling methodology is a powerful techni-
que for the determination of the volatile composition of
the head-space above the examined yeast cultures. It
allows for the detection of volatiles present in minute
amounts, while when combined with signal calibration
using standard compounds (see methods) it can provide
adequately accurate determination of production yields.
However, SPME sampling cannot provide information
on the levels of compounds retained in the intracellular
space, the cell membrane, or in the medium. To assess
these quantities and to provide an SPME-independent
evaluation of terpene yields in the improved strains,
liquid-liquid extractions were performed. Cultures were
induced for 3 days and extracted with an 85:15 mix of
hexane/ethyl acetate according to the method described
by Takahashi [29]. The extracted material was purified
by silica gel column chromatography and the purified
fractions were analyzed by GC-MS and quantified. The
strain AM78-01 expressing cineole synthase yielded 28.5
mg/g dry weight (DW) of cell mass which was 3.4-fold
higher than in control BY4741-02 cells. The strain
AM78-07 which additionally expressed IDI1and HMG2
(K6R) from a plasmid produced 99 mg/g DW, which
was 11-fold higher than control cells (Figure 7A).
Extraction of sesquiterpenes from SpP330 cells did not
exhibit high yields, 4.6 mg/g DW for AM70-02 and 1.1
mg/g DW for BY4741-04. The difference in yield
amounts to 4.18-fold (Figure 7B).
The relative proportions of terpenes identified by
SPME and by liquid-liquid extraction of cineole produ-
cing strains differed. The major compound identified
was b-pinene reaching 31.59% of the total yield. Limo-
nene and cineole were present in almost equal propor-
tions 13.36% and 12.69% respectively. The SpP330
extraction results gave low yields of only two sesquiter-
penes a-humulene at 52.06% and a-guaine at 35.43%,
which were only minor compounds by SPME. These dif-
ferences likely reflect the differential solubility of the
products in an aqueous environment or in the cell
membrane. Nevertheless, the yields measured using
liquid-liquid extractions confirm the positive effect of
the applied genetic modifications in terpene production.
Comparison of the plant essential oil analysis in S. fru-
ticosa and S. pomifera in respect with the product pro-
files identified by SPME GC-MS analysis, of SfCinS1
and SpP330 expressing cells, identified a number of
common compounds (Table 2) [30-32]. They are pre-
sent in substantial quantities in the yeast assays. For ses-
quiterpenes, a-cubebene, caryophyllene, a-humulene
and δ-cadinene produced in yeast cells expressing
SpP330, are also found in S. pomifera plants. The com-
pounds a-copaene, g-gurjunene and cadina-1,4-diene
are encountered in the yeast system but not in plants
(Table 2). A number of compounds produced in planta
though are likely to be further modified by additional
enzymes. The improved yeast strains could be helpful in
identifying the substrate specificity of enzymes which
have been difficult to characterize using in-vitro assays.
An HSP90 protein isolated from a two-hybrid screen as
SfCinS1 interactor enhances cineole production in yeast
Complementary to the upregulation of the endogenous
biosynthetic pathway to increase cineole production, we
undertook to examine whether we could enhance terpene
production by improving the capacity of cineole synthase.
The isolation of terpene synthase interacting proteins,
which participate in the folding, stability or localization of
the enzyme, could identify additional aspects of the bio-
synthetic process that could be improved and incorporated
into a yeast biotechnological production system approach
[33]. To this end, a S. fruticosa glandular trichome cDNA
library was transferred into a modified pJG4-5 library vec-
tor. Additionally a “bait” vector [34] was constructed so as
to incorporate the LexA fused to the C-terminus of
SfCinS1 to minimize interference of the fused moiety to
A B 
Figure 7 Terpenoid yields from Hexane/ethyl acetate LL
extraction in 3 days old cultures. (A) A 3.3-fold increase and 11-
fold increase of terpenes extracted is observed between AM78-01,
AM78-08 respectively compared to control cells. (B) A 2.6-fold
increase and 4-fold increase of terpenes extracted is observed
between AM68-05, AM78-10 respectively compared to control cells.
(C) A 4.2-fold increase in terpenes extracted is observed between
AM70-02 cells and BY4741-04 cells expressing the SpP330
sesquiterpene synthase.
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SfCinS1-LexA fusion was an active enzyme. The library
was introduced into EGY48 yeast reporter cells carrying
the SfCinS1-LexA “bait” plasmid. In a pilot screen twenty
four colonies were isolated and further processed to
extract the library plasmids. Five isolates which were dis-
tinctly different in insert cDNA size were tested in fresh
cells for the reproducibility of the interactions. The iso-
lated library clones were transformed back into fresh
EGY48-01 cells carrying the SfCinS1-LexA fusion and
EGY48-02 cells carrying the LexA protein only. Trans-
formed colonies were replica plated in glucose and galac-
tose plates lacking leucine. Growth appeared only in
EGY48-01 cells expressing the LexA-SfCinS1 with the
putative interactors in galactose plates where proteins are
expressed from the PGal1 promoter (Figure 8A).
Three of the isolates C4, D4 and D1 (Figure 8A)
passed successfully these tests, as they interacted specifi-
cally with the SfCinS1 but not the LexA alone. The
cDNAs encode for a luminal binding protein, BiP5
(clone C4), a Heat Shock Protein 90 (clone D4) and a
SEC14 homologous protein (clone D1). All three cDNAs
were subsequently identified as multiple isolates. We
focused initially on the HSP90 protein, as chaperones
are known to affect the folding of their binding partners.
Cineole synthase and the HSP90 protein were co-
expressed in EG60-06 parental and AM78-09 improved
yeast cells. The presence of HSP90 led to a 60% increase
in cineole production in EG60-05 cells, and a 20%
improvement in the high cineole producing AM78-08
cells (Figure 8B). The results indicate that proteins
potentially interacting with cineole synthase could also
augment productivity.
Discussion
Terpenoids are members of a vast group of secondary
metabolites which include sterols, polyprenyl alcohols, car-
otenoids, ubiquinone (coenzyme Q), and heme A. Com-
mercial interest for them is very high, for their properties
as food colorants and antioxidants (carotenoids) [35],
Table 2 Percentage of mono- and sesquiterpene products produced in plants, in yeast cells, and in enzymatic assays
with bacterially expressed protein
Compounds Salvia fruticosa
plants (%)
Salvia pomifera
plants (%)
SfCinS1
SPME (%)
SfCinS1
LLE (%)
SfCinS1
in-vitro (%)
P330
SPME (%)
P330
LLE (%)
a-Thujene 0.30 - 1.04 0.24 - 0.84 - - - - -
a-Pinene 2.58 - 6.26 0.42 - 2.40 7.78 16.89 4.6 - -
Camphene 0.17 - 1.05 0.51 - 4.42 - - - - -
Sabinene 0.31 - 0.69 1.00 - 2.65 - 3.14 3.6 - -
b-Pinene 8.92 - 18.77 0.40 - 1.85 8.10 31.59 9.1 - -
b-Myrcene 1.47 - 5.03 0.48 - 1.38 4.9 4.65 2.2 - -
a-Phellandrene - - - 4.16 - - -
Limonene 0.06 - 1.28 0.27 - 0.59 - 13.36 <1.0 - 12.5
1,8-Cineole 22.70 - 49.20 0.09 - 0.20 75.09 12.69 72.4 - -
a-Terpinene 0.38 - 0.80 0.20 - 0.49 3.57 0.33 - - -
g-Terpinene 3.33 -
a-Terpineol - - 0.54 2.22 7.1 - -
a-Thujone 0.30 - 3.53 9.8 - 47.35 - - - - -
b-Thujone 0.22 - 1.72 17.8 - 27.72 - - - - -
Camphor 0.13 - 1.72 0.34 - 1.18 - - - - -
Borneol 0.51 - 1.34 0.14 - 0.93 - - - - -
Geraniol - - - 6.89 - - -
a-Cubebene 0.26 - 0.19 1.40 - 4.68 - - - 10.57 -
a-Copaene - - - - - 14.45 -
Caryophyllene 4.64 - 12.75 7.82 - 22.75 - - - 11.25 -
a-Guaiene - - - - - 1.24 35.43
a-Humulene 2.18 - 4.13 0.43 - 1.49 - - - 1.86 52.06
g-Gurjunene - - - - - 2.40 -
Germacrene A - - - 0.41 - - -
Germacrene D - - - 0.27 - - -
Curcumene 0.03 - 0.18 0.12 - 5.16 - - - - -
Cadinene 0.03 - 0.70 2.29 - 8.00 - - - 50.61 -
Cadina-1,4-diene - - - - - 4.58 -
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(ubiquinone) [36], antiparasitic (artemisinin) [14] and anti-
neoplastic (taxol) agents [3] and biofuels (farnesene,
pinene) [5,6]. Although terpenoids are structurally hetero-
geneous, exhibiting hundreds of different carbon skele-
tons, they all derive from the universal precursor
isopentenyl diphosphate (IPP) and its allylic isomer
DMAPP. In yeast these precursors are intermediate pro-
ducts of the mevalonate biosynthetic pathway responsible
for sterol biosynthesis. Sterols are important for the phy-
siology of a eukaryotic organism as they form part of the
cellular membrane where they modulate their fluidity and
function. Ergosterol is the main sterol produced in yeast
and is an important constituent of secretory vesicles and
for mitochondrial respiration [37,38]. The presence of ter-
penoid enzymatic precursors, the in-depth understanding
of yeast genetics and physiology and the capacity to intro-
duce extensive genetic modifications, attracted early on
the focus of research towards biotechnological production
of terpenoids in yeast [14,17,39,40]. The approach under-
taken presently aimed to develop a system for introducing
unlimited successive modifications without the incorpora-
tion of undesired bacterial plasmid sequences. The wild
type EG60 strain was identified as more capable of produ-
cing substantially higher levels of cineole than the standard
reference strain BY4741. EG60 cells were previously
observed to be very efficient in respiration, to exhibit
increased resistance to oxidative stress [41] and produce
higher levels of squalene (unpublished data). Extensive
variability between various wild type strains was also
observed recently by Ohto and co-workers testing ATCC
yeast strains for prenyl alcohol production [19].
The enzyme 3-hydroxy-3-methylglutaryl-coenzyme A
reductase (HMGR) is of key importance in the mevalo-
nate pathway and is subject to feedback regulation as
part of the cellular control of sterol biosynthesis [23].
Yeast has 2 isozymes of HMG-CoA reductase, called
hmg1p and hmg2p encoded by HMG1 and HMG2
genes respectively. Between the two HMG genes in
yeast, Hmg1p is quite stable, whereas Hmg2p undergoes
sterol pathway degradation [24]. Recently, Garza and
colleagues showed that naturally synthesized GGPP con-
trols Hmg2p stability by directly altering the structure
of the protein [42]. The choice of the K6R mutation in
HMG2 aimed to maintain the specific localization of the
enzyme, which is mostly perinuclear with intense bead-
like foci, while suppressing degradation [43]. Proper
localization of the enzyme could be of importance to
toxicity, as overexpression of tHmg1 was reported to
result in growth properties reduction in yeast strains
[44]. Expression of HMG2 (K6R) either from a high
copy number plasmid or from a genome integrated
extra copy did not alter the growth properties of the
strains used [44].
The first cassette developed in this work, COD1,
incorporated in the HO locus the K6R variant form of
HMG2, thus making HMG2 more stable (Figure 3A).
The URA3 selection marker was subsequently removed
by hisG recombination. This gave rise to strains AM63
and AM65 (haploid) and AM66 (diploid) which pro-
duced substantially higher levels of monoterpenes than
parental EG60 cells. Since the COD1 cassette, which
was based on D. Stillman’s vector [20], could only be
used for a single integration into the HO locus, we
undertook to develop integration vectors that would
enable the stable integration of strong promoters or
composite inserts (promoter-gene-termination sequence)
in any desirable genomic locus. The promoter insertion
approach was tested on the ERG20 gene which encodes
the farnesyl diphosphate synthase, a key enzyme catalyz-
ing the sequential head-to-tail condensations of isopente-
nyl diphosphate (IPP, C5) with dimethylallyl diphosphate
(DMAPP, C5) and GPP to give FPP [26]. Introduction of
A
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Figure 8 The putative interacting HSP90 synergizes with
SfCinS1 to increase cineole production. (A) EGY48 yeast reporter
cells carrying the SfCinS1-LexA (top row) or the LexA plasmid
(bottom row) with the five (C2, C4, D1, D4, D6) library cDNAs were
replica plated on glucose/CM-his, trp, leu and galactose-raffinose/
CM-his, trp, leu agar media. Growth is observed only for the
SfCinS1-LexA fusion in the galactose based media, where proteins
are expressed, confirming the specificity of interactions. (B) EG60-05
cells and AM78-08 cells carrying SfCinS1 with empty vector (light
grey) and EG60-05 and AM78-09 cells carrying SfCinS1 with HSP90
(dark grey), were tested for cineole production. The presence of
HSP90 enhances cineole yield for both strains.
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the ERG20 allele led to an increase in cineole, as well as
sesquiterpene (a-cubebene, a-copaene, trans-caryophyl-
lene and δ-cadinene), production ((Figures 4A and 4G).
Further increases of ERG20 levels by expressing the gene
from a PGal1 plasmid did not lead to any additional
monoterpene increases and were mildly toxic (data not
shown). Interestingly, decreasing the abundance of ERG9
squalene synthase by eliminating one allele caused a
decrease in monoterpene production, but a substantial
increase in sesquiterpene production. This may be due to
FPP accumulation which probably inhibits erg20p
through product inhibition, thus lowering the availability
of GPP [26,45]. In the AM70-02 cells no such inhibition
is observed since the SpP330 enzyme consumes FPP to
synthesize sesquiterpenes.
ERG9 downregulation has previously been obtained by
replacing the endogenous ERG9 promoter with a regula-
table MET3 promoter, that is repressed in the presence
of methionine [15]. Previous observations in allele inacti-
vated diploid strains had shown that in at least 80% of
the genes tested this heterozygocity leads to almost 50%
reduction in protein levels [46,47]. As anticipated ERG9/
erg9 heterozygocity is shown to cause an increase in ses-
quiterpene production. This approach may have some
merit as it does not require changes in the nutrient med-
ium, which could add an extra level of complexity in a
production system. Moreover, it did not cause a growth
impediment, and, in principle, additional genes could be
targeted for allele inactivation, either in the downstream
pathway or in side-pathways draining the substrate sup-
ply. In reported strains with downregulated ERG9 expres-
sing the sesquiterpene synthase cubebol synthase,
farnesol production has been reported to accumulate as
resulted of increased FPP availability [44]. No farnesol
was detected upon expression of the S. pomifera P330
enzyme. On the other hand, the presence of farnesol was
manifested when a different sesquiterpene synthase
enzyme isolated from S. fruticosa was expressed. In the
strain with erg9 allele inactivation, farnesol comprised
almost 50% of the total yield (data not shown).
Shifting the balance towards GPP production was
achieved by overexpression of IDI1, initially from a plas-
mid and subsequently by integrating a cassette PGal1-
IDI1-ts into the mutant leu2 locus of the AM65 strain.
The strain developed was capable of high monoterpene
production while maintaining robustness, thus enabling
more changes in the metabolic pathway to further
increase production levels. Using the cre-loxP recyclable
cassette system no bacterial plasmid sequences are
incorporated in the yeast genome, which would not be
desirable for certain applications such as production of
compounds as food supplements i.e. carotenoids where
consumer acceptance is an issue
The central function of a terpenoid synthase is to bind
to the flexible isoprenoid substrate and chaperone the
orientation and rotational alterations of the substrate
and the reaction intermediates. A significant factor con-
tributing to the multitude of terpenoids found in nature
is the formation of multiple products. Almost half of all
characterized monoterpene and sesquiterpene synthases
also form significant amounts of additional products
when the expressed protein is assayed in-vitro [48]. This
maybe a consequence of high conformational flexibility
in the active center, which allows the formation of more
reaction intermediates and thus more products. There is
no unique feature of the terpene synthases that distin-
guishes multiple from single product enzymes. Small
changes in critical residues can alter dramatically the
product profile. Previous work in our lab, showed that
t h ec o n v e r s i o no fo n l yf i v ea m i n oa c i dr e s i d u e si n
1,8-cineole synthase of Salvia fruticosa,r e s u l t e di n
switching of the product profile in favor of sabinene as
sole product [30]. This is also the case for sesquiterpene
synthases. Mutations in four amino acid residues in the
active center of Abies grandis g-humulene synthase led
to the formation of seven enzymes with different spectra
of product specificities [49]. One parameter that should
be taken into consideration in the yeast terpene produc-
tion system is the catalytic capacity of the individual
enzyme used. It would be interesting to assess whether
mutations could be introduced to the enzymes which
w o u l di m p r o v et h e i rs p e c i f i ca c t i v i t yo ri n c r e a s et h e i r
product specificity.
We postulated that an additional strategy to increase
production of terpenoids in yeast is by co-expressing
plant interacting proteins to biosynthetic enzymes. These
interactors could facilitate folding of the enzymes, storage
and/or secretion of produced compounds. In the pilot
screen performed, using a library from glandular tri-
chomes of Salvia fruticosa, the three identified proteins
are directly relevant to such putative functions. Isolate
C4 is a luminal binding protein (BiP), a conserved mem-
ber of the HSP70 family that is known to bind to incom-
pletely assembled or misfolded proteins in the lumen of
the ER [50,51]. Loss of BiP function blocks translocation
of secretory proteins in yeast [52]. In plants BiP tran-
scription can be induced by the unfolded protein
response. Isolate D1 is homologous to the Arabidopsis
SEC14 cytosolic family protein. The SEC14 superfamily
consists of greater than 500 members of which the yeast
Sec14p is the prototype. Sec14p-like proteins have been
adapted during evolution to fulfill a variety of functions
that depend on protein-lipid interactions [53]. Isolate D4
which belongs to the family of HSP90-2 proteins was
chosen for further characterization. HSP90 proteins are
distinct among molecular chaperones in the functionally
diverse but numerically restricted substrate proteins
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dies have shown the involvement of HSP90 in promoting
developmental robustness [54,55]. The HSP90 protein,
when overexpressed together with SfCinS1, resulted in a
significant production increase confirming the original
hypothesis. Co-expression of selected interactors could
be an additional strategy in the biotechnological produc-
tion of terpenoids.
Conclusion
Yeast strains exhibit high variability in terpenoid pro-
duction. A suitable wild type strain was selected for
improvement. A series of cassettes were developed
which allow the integration of any desired genetic ele-
ment into the yeast genome at suitable loci, avoiding the
introduction of unnecessary exogenous DNA sequences.
The tools were applied for the generation of new strains
with upregulated biosynthesis of terpenoid precursors.
The improved yeast strains yielded higher terpenoid
levels. Co-expression from high copy number plasmids
of IDI1 and HMG2 (K6R) in the AM78 strain yielded
60% higher monoterpene levels than co-expression in
the parental background, indicating that the system is
not yet saturated. Additionally, we aimed to stabilize the
plant cineole synthase SfCinS1, by co-expressing its
interacting partner HSP90, which also led to production
increases.
Methods
Chemicals and materials
SPME fiber 2 cm-50/30um DVB/Carboxen™/PDMS
StableFlex™ Fiber (Supelco);. 1,8 cineole (Aldrich,
C8,060-1), g-terpinene (Aldrich, T2134), a-pinene
(Aldrich, P-7408), b-myrcene (M-0382) and (-)-trans-
caryophyllene (Sigma, C9653-5), a-copaene (Aldrich,
27814) and a 70% Sabinene solution kindly donated by
VIORYL Chemicals, were used as standard compounds.
Myc-Tag (9B11) mouse mAb, (#2276, Cell Signaling);
HA-Tag (6E2) mouse mAb, (#2367, Cell Signaling) and
Anti-Mouse IgG (Fab specific)-Peroxidase antibody
(Sigma, A9917) were used for protein detection. Yeast
media: D (+)-Glucose monohydrate (16301, Sigma);
D-(+) Galactose (G0625, Sigma); Raffinose pentahydrate
(R1030, US Biological); Yeast Nitrogen Base w/o AA,
carbohydrate & w/AS (Y2025, US Biologicals); Complete
M i n i m a l( C M )m e d i u mi sc o m p o s e do f0 . 1 3 %( w / v )
dropout powder (all essential amino acids), 0.67% (w/v)
yeast nitrogen base w/o AA, 2% glucose. For galactose
based medium glucose is substituted with 2% galactose,
1% raffinose; 5’-Fluoroorotic acid monohydrate (F5050,
US Biologicals); b-glucuronidase (G7017 Sigma); TOPO
TA Cloning Kit Dual Promoter (K4610-20, Invitrogen);
SuperSignal West Pico Chemiluminescent Substrate
(34077, Thermo Scientific).
Gene cloning and expression in yeast
The following expression plasmids were used for expres-
sion in yeast cells: pYES2 (URA3,2 μ,G a lp r o m . ) ;
pYES2-myc (URA3,2 μ,P Gal1,m y ct a g ) ;p J G 4 - 4 ( TRP1,
2μ,P Gal1); pJG4-6 (TRP1,2 μ,P Gal1,H A - t a g ) ;p J G 4 - 5
(TRP1,2 μ,P Gal1, B42AD-HA); pYX143 (LEU2, ars/cen,
PTPI); pYX143-HA (LEU2,a r s / c e n ,P TPI, HA tag); pYES-
ADH1 (URA3,2 μ,P ADH1). The pYIC1 vector was con-
structed by integration of the LEU2 orf, which was PCR
amplified using 5’URA-LEU 5’-ACTGCACAGAA-
CAAAAACCTGCAGGAAACGAAGATAAA TCATG
TCGCCCCTAAGAAGATCGT-3’ and 3’URA-LEU
5’-AGTTTAGTATACAT GCATTTACTTATAATA
CAGTTTTTTAAGCAAGGATTTTCTTAACTTC -3’
primers, into the pYES2 plasmid replacing the URA3
marker. The success of recombination was confirmed by
PCR and auxotrophic complementation of the new vec-
tor. The gene PCR amplifications were performed using
Platinum Taq (Invitrogen) or Hotstar Taq (Qiagen)
were cloned by TOPO TA cloning into the pCRII vector
(Invitrogen). The cloned amplified products were sub-
mitted for DNA sequencing prior to additional manipu-
lations. The open reading frame minus the transit
peptide (orf) of S. fruticosa cineole synthase 1 (SfCinS1,
Acc. DQ785793) was PCR amplified from a previously
isolated full length cDNA [30] using the primers
5’SfCinS1(+RR) 5’-GAATTCATG CGACGAACTGG
AGGCTACCAGC-3’ and 3’Sf CinS1(XhoI) 5’-CTC
GAGTTAC T CATAGCGGTGGAACAG-3’. The yeast
gene isoprenyl diphosphate synthase (YPL117c, Acc.
NP_015208) was PCR amplified from yeast genomic
DNA using the primers 5’-IDI(EcoRI) 5’-GAATTCATG
ACTGCCGACAACAATAGTA TGCCCC-3’ and 3’-IDI
(XhoI)5’-CTCGAGTTATAGCATTCTATGAATTTG
CCTGTCAT-3’.T h es p r u c e( Picea abies) isoprenyl
diphosphate synthase PalIDS1 (Acc. GQ369788) was
PCR amplified from a full length cDNA, kindly donated
by Dr. Gershenzon using the primers 5’GPPS(EcoRI)
5’-GAATTCATGTGCTCAAACACAAATGCCCAG-3’
and 3’-GPPS(XhoI) 5’-CTCGAGTCAGTTCTGTCTT
TGTGCAATGTA-3’.T h eS. pomifera putative sesqui-
terpene synthase P330 was PCR amplified from a pre-
viously isolated full length cDNA clone (unpublished
data) using the primers 5’P330(BamHI) 5’-TGGATCC
GAGCTGAAATATATGCATCGGCT-3’ and 3’P330
5’-TGATGGAGTTTGATTC TAGACCT-3’.T h eArabi-
dopsis thaliana HSP90 orf was PCR amplified from the
recombinant clone RALF06-10-K09, (RIKEN Arabidop-
sis) using the following primers: 5’HSP90(BamHI)
5’-GGATCCATGGCGGACGCAGAAACCTT-3’ and
3’HS P90(XhoI) 5’-CTCGAGGTCAACTTCCTCC
ATCTTG CT -3’. Expression of the proteins was veri-
fied in pYX143-HA, pJG4-6, pYES-myc constructs in
western blots using antibodies against the hemaglutinin
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vector counterparts were used to eliminate the possibi-
lity of any interference of the tags.
Preparation of integration cassettes for yeast
transformation
Using genomic DNA from the S. cerevisiae strain
BY4741 as template, the gene HMG2 was PCR amplified
with a 5’ primer 5’HMG2 (K6R) 5’-ATGTCACT
TCCCTTAAGAAC GATAGTACATTTG-3’ which
introduced a point mutation at K6 converting it to R
and a 3’ primer 3’HMG2(XhoI) 5’-CTCGAGTTATAA-
TAATGC TGAGGTTTTACAGGGGGG-3’.T h eP C R
product was cloned by TOPO TA cloning (Invitrogen)
and sequenced. The galactose promoter (Pgal1)-multi-
cloning site(mcs)-terminator sequence (ts) was PCR
a m p l i f i e df r o may e a s te x p r e s s i o nv e c t o ru s i n gp r i m e r s
5’GAL(MfeI) 5’-CAATTGTTTAAACGGATTAGAAG
CCGCCGAGCG-3’ and 3’CYC1(BglII) 5’-AGATCT
GGCCGCAAATTAAAGCCTTCG-3’. The fragment was
cloned by TOPO TA cloning and was subsequently
transferred into the M4366 vector (Acc. AF324729) gen-
erating the construct M4366-Gal1p (HOR-Pgal1-mcs-ts-
hisG-URA3-hisG-HOL). The HMG2 (K6R) cDNA was
excised with EcoRI and the insert was ligated into the
M4366-Gal1p vector at the EcoRI site. The orientation
of the cDNA relative to the promoter was first assayed
using primers from the PGal1 and the 3’ of the gene
(Figure 3A). The positive construct was additionally vali-
dated by DNA sequencing using a primer from the
Galp. The full cassette named COD1 (HOR-PGal1-
HMG2 (K6R)-ts-hisG-URA3-hisG-HOL) was linearized
by digestion with NotI and was transformed into the
EG60 strain. Colonies growing in Glucose/CM-ura were
selected and tested for integration using genomic DNA
as template and primers from the PGal1 and the HMG2
(K6R) cDNA. The strain was named AM63. The URA3
selection marker was excised by plating cells on 5-FOA
plates which counter-select for the presence of URA3.
The hisG sequences flanking URA3 recombine causing
the elimination of the gene. Growing colonies were
tested by replica plating on Glucose/CM-ura and were
found to be ura deficient. A strain of the opposite mat-
ing type containing the same COD1 cassette was
crossed to AM63 to create a diploid strain homozygous
for COD1. The strain was named AM66.
Development of COD2 cassette
The galactose promoter was PCR amplified using the
primers 5’-GAL(SfiI) 5’-AGTGGCCTATGCGGCCACG-
GATTAGAAGCCGCCGA-3’ and 3’-GAL 5’-AATTCG-
GATCCAGAGGCATAATCTGGCACATCATACATG-
3’ which introduce an SfiIs i t ea t5 ’ of the PGal1 promo-
ter. The amplified product was cloned into the pCRII
TOPO vector. The construct which contained the SfiI
site of the PGal1 proximal to the HindIII site of the vec-
tor was used for additional manipulation. The loxP-
URA3-loxP fragment from the pUG72 vector was
excised by digestion with HindIII and SfiI and inserted
into the pCRII- PGal1 plasmid, giving rise to COD2 cas-
sette (loxP-URA3-loxP-PGal1). The ADH1 promoter was
PCR amplified using the primers SpeI-SfiI 5’ADH
5’-ACTAGTGGCCTATGCGGCCTATTTCGGATATCC
TTTTGTTG-3’ and 3’- ADH (HindIII) 5’-AAGCTTGG
AGTTGATTGTATGCTTG-3’ which introduce and SfiI
and a HindIII site at the 5’ and 3’ of PAdh1 respectively.
The PCR product was cloned and inserted into the
pUG72 vector as above, giving rise to the COD3 cassette
(loxP-URA3-loxP-PAdh1.)
To integrate PGal1 upstream of the ERG20,u s i n ga sa
template the COD2 cassette the loxP-URA3-loxP- PGal1-
HA sequence was PCR amplified by using the following
primers: ERG20-COD2-for 5’-CTCAACCAACAGG-
TATTGGACTGACATAGGCACAATAAACTCAAA
AATAAAGCTTCGTACGCTGCAGG-3’ and ERG20-
COD2-rev 5’-GGGAAAACGTTC AAGAATCTCTC
TCTCCTAATTTCTTTTTCTGAAGCCATGGATCCA
GAGGCATAAT CT-3’. The products of six PCR ampli-
fications were pooled and purified by phenol/chloroform
extraction and ethanol precipitation. The DNA was used
in a lithium acetate transformation to transform AM66
cells. Colonies growing in glucose/CM-ura plates were
selected and tested for proper integration of the promo-
ter using genomic DNA from the URA+ colonies
and primers 5’GALprom and 3’ ERG20 confREV
5’-TTGGAAGGTGACCTCATG GAACAATTCG-3’.
The PCR products were resolved by agarose gel electro-
phoresis. Six out of eight tested colonies carried the spe-
cific integration. The strain was named AM67. Excision
of the URA cassette was achieved by transformation
with the plasmid pB227Galp-Cre which expresses the
Cre recombinase under the control of the galactose pro-
moter. Cells harbouring the plasmid were plated in
Galactose-raffinose/CM-leu media and grown colonies
were tested for uracil auxotrophy. The selected ura cells
were cured of the plasmid and were named AM68.
Development of COD4 and COD40 cassettes
The PGal1-mcs-ts was PCR amplified from an expression
vector using the primers 5’-GAL (HindIII) 5’-AAGCT-
TACGGATT AGAAGCCGCCGAG-3’ and 3’-ts(SalI)
5’-GTCGACGGCCGCAAATTAAAG CCTTCG-3’.T h e
amplified PCR product was purified by gel extraction
a n dc l o n e di n t ot h ep C R I Iv e c t o ri naT O P OT Ar e a c -
tion. The pUG27 vector [27] was modified to destroy
the XhoI restriction site. The full cassette was excised
using HindIII and SalI and subcloned into the pUG27
modified vector digested with the above enzymes, giving
rise to the COD4 cassette. The IDI1 orf was inserted
into the COD4 plasmid using the EcoRI and XhoI
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cassette. The previously mutated leu2 gene was chosen
as the site of integration of the COD4 cassette. The cas-
sette was amplified in PCR reactions using the primers
LEU2-pUGF 5’-ATGTCTGCCCCTAAGAAGATCGTC
GTTTTGCCAGGT GACCACGTTGGTCAGCTTACG-
GATTAGAAGCCGC-3’ and LEU2-pUG Rev 5’-AG
CAAGGATTTTCTTAACTTCTTCGGCGACAGCAT
CACCGACTTCGGTGGATAGGC CACTAGTGGAT
CTG-3’ and purified as above. The DNA was used to
transform AM65 cells. Transformed cells were selected
for growth in glucose/CM- his plates. The cells were
named AM77.
Generation of erg9 haploinsufficient yeast cells
To generate a deletion in one of the two alleles of the
diploid AM68 cells, the pUG27 cassette containing the
his5+ from S. pombe flanked by loxP sites was PCR
amplified using primers EGR9-pUG F 5’-AGAGAAAA-
GACGAAGAGCAGAAGCGGAAAACGTATACACGT-
CACATA TCACAGCTGACTTCGTACGC-3’ and ER
G9-pUG R 5’-GTACTTAGTTATTGT TCGGAGT
TGTTTGTTTATGTTATTTGGCGCAGACTGCATA
GGCCACTAGTGGATCTG-3’. AM68 cells were trans-
formed as above and colonies growing in glucose/CM-
his. The stable integration of disruption cassette was
confirmed by PCR amplification of a 500 bp fragment
using the primers ERG9prom 5’-CTAAA CGAGCAGC-
GAGAACACGACCAC-3’ and pUG27confR 5’-GG
ATGTGATGT GAGAACTGTATCC-3’.T h eP C Rp r o -
duct was resolved by electrophoresis on 1% agarose gel.
Terpene production in yeast
The developed S. cerevisiae strains carrying the plasmids
for terpene expression were initially grown in 5 ml over-
night cultures in glucose based selective media at 30°C.
In the following day 50 ml fresh glucose media was
inoculated from the grown cells to an OD600 =0 . 1a n d
incubated shaking at 30°C until the OD600 reached 0.5-
0.7. The cultures were pelleted and washed twice with
sterile ddH2O. The washed pellets were resuspended in
50 ml of Galactose-Raffinose based selective growth
medium and incubated at 30°C ~12 hours. The induced
cultures were either kept in the medium and assayed in
regular intervals, or washed twice with sterile ddH2O
and resuspended in 20 ml of buffer (10 mM MOPS, 2
mM MgCl2,0 . 2m MM n C l 2,2 %G l y c e r o l ,1m MD T T )
and incubated at 30°C from 12 hours to several days.
When the incubation on buffer was prolonged more
than 12 hours the accumulated volatiles were released
every 24 hours. Measurements to assess levels of pro-
duction were performed on cells kept in galactose-raffi-
nose media, while product identification assays and
assays for extended periods were performed on cells
kept in buffer. Volatiles sampling was performed using a
Solid Phase Microextraction (SPME) assembly. The
SPME method was performed by using 2 cm-50/30um
DVB/Carboxen™/PDMS StableFlex™ Fiber for Manual
Sampling. Yeast cells, resuspended in 20 ml of buffer
( 1 0m MM O P S ,2m MM g C l 2, 0.2 mM MnCl2,2 %G l y -
cerol, 1 mM DTT) and incubated at 30°C, were sampled
by exposing the SPME fiber for 30 min into the head-
space (using a 250 ml Erlenmeyer flask). 1,8 cineole,
g-terpinene, a-pinene, b-myrcene and (-)-trans-caryo-
phyllene were used as standard compounds. They were
dissolved in pentane and ten-fold serial dilutions were
prepared. 10 μl from each dilution was added to 20 ml
buffer solution and exposed to SPME sampling in iden-
tical conditions to the cultures tested, and subsequently
measured by GC. The GC cineole peak area values were
plotted against the concentration of the compound.
The exposed SPME fiber was withdrawn into the
outer septum-piercing needle, removed from the flask,
and inserted in the heated injection port of the gas
chromatograph. The products were identified by com-
paring retention times and mass spectra with authentic
reference compounds. In-vitro enzyme assays were per-
formed in yeast cell extracts broken by sonication
according to the method described by Kampranis et al
[30]. The GC apparatus used is a Hewlett Packard 5890
II gas chromatograph equipped with flame ionization
detector capillary column HB5 30 m long, with
0.25 mm in diameter and 0.25 μm film thickness. Tem-
perature of injector and detector were 230°C and 270°C,
respectively; oven temperature was programmed initially
at 60°C for 3 min and then increased with a rate of 3°C/
min with a final isotherm at 230°C for 20 min. The car-
rier gas used for the analysis was Helium (He) at con-
stant pressure of 127 kPa, at 37.1 cm/s velocity. For
terpene verification the analytes were thermally des-
orbed at 230°C from SPME fiber into the injector of a
QP2010 Shimadzu gas chromatograph equipped with
QP2010 mass selective detector, and a ZB5 (0,25 mm ×
30 m, 0,25 μm film thickness) column, in the splitless
mode. A further refinement present in the GC/MS is
that the coated capillary column is placed in an oven
whose temperature is slowly raised with a rate of 3°C/
min from 60°C up to 240°C and maintained at this tem-
perature for 5 min to equilibrate. This slow rise in tem-
perature helps to elute compounds with higher boiling
points that may not be in gaseous phase in the begin-
n i n go ft h er u n .O n c eo u to ft h ec o l u m nt h eF I Dw i l l
detect the compound.
Liquid-liquid extraction was performed with selected
yeast strains which were evaluated for terpene produc-
tion using 100 ml cultures incubated at 30°C for 3
days. The cultures were extracted with 15% ethyl acet-
ate, 85% hexane [29]. The cell mass concentration was
determined by centrifugation of the cell cultures. The
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and weighted. Preparative column chromatography was
performed to purify the extracted product, which was
concentrated under N2 steam to approximately 10% of
the original volume and then applied to a silica gel col-
umn (5 × 70 mm). Terpenes were then eluted with
90% pentane, 10% diethyl ether in serial fractions. The
presence of the products in the separated fractions was
confirmed by thin layer chromatography and the iden-
tified fractions carrying the products were further ana-
lyzed by GC-MS. The amount of purified product was
reported to the dry weight (DW) of the corresponding
cell pellet.
Yeast genetic screen for CinS1 interacting proteins
The SfCinS1 PCR amplified insert cloned into the pCRII
TOPO vector was digested with EcoRI and XhoI and
subcloned into the pGILDA vector linearized with the
above restriction enzymes. The composite construct
fuses in frame the LexA moiety of the vector with
CinS1. Expression of the LexA-CinS1 was verified using
antibodies against the LexA part of the fusion protein.
A tomato cDNA library cloned into the pJG4-5 vector
was screened as previously described [34,56]. Interacting
library clones were examined for specificity and sub-
mitted for DNA sequencing.
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